3SBio Inc. (HKG:1530)

Hong Kong · Delayed Price · Currency is HKD

25.38

+0.06 (0.24%)

Apr 2, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Development, Production, Marketing and Sale of Biopharmaceutical Products	17.70B	9.11B	7.82B	6.87B	6.38B
Development, Production, Marketing and Sale of Biopharmaceutical Products Growth	94.29%	16.53%	13.84%	7.58%	14.22%
Total	17.70B	9.11B	7.82B	6.87B	6.38B
Total Growth	94.29%	16.53%	13.84%	7.58%	14.22%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Mainland China	7.91B	8.85B	7.60B	6.66B	6.24B
Mainland China Growth	-10.63%	16.48%	14.14%	6.67%	15.13%
Usa	9.52B	-	-	-	-
Others	270.43M	257.28M	217.43M	208.75M	141.09M
Others Growth	5.11%	18.33%	4.16%	47.96%	-15.36%
Total	17.70B	9.11B	7.82B	6.87B	6.38B
Total Growth	94.29%	16.53%	13.84%	7.58%	14.22%

Source: S&P Global Market Intelligence.